189 related articles for article (PubMed ID: 7221194)
1. Lung function in cystic fibrosis: acute effect of salbutamol.
Svenonius E; Arborelius M; Kautto R; Kornfält R; Lindberg T
Respiration; 1980; 40(4):226-32. PubMed ID: 7221194
[TBL] [Abstract][Full Text] [Related]
2. Effect of salbutamol on gas compression in cystic fibrosis and asthma.
Desmond KJ; Demizio DL; Allen PD; MacDonald ND; Coates AL
Am J Respir Crit Care Med; 1994 Mar; 149(3 Pt 1):673-7. PubMed ID: 8118635
[TBL] [Abstract][Full Text] [Related]
3. Multiple-breath inert gas washout and spirometry versus structural lung disease in cystic fibrosis.
Gustafsson PM; De Jong PA; Tiddens HA; Lindblad A
Thorax; 2008 Feb; 63(2):129-34. PubMed ID: 17675316
[TBL] [Abstract][Full Text] [Related]
4. Multiple breath inert gas washout as a measure of ventilation distribution in children with cystic fibrosis.
Aurora P; Gustafsson P; Bush A; Lindblad A; Oliver C; Wallis CE; Stocks J
Thorax; 2004 Dec; 59(12):1068-73. PubMed ID: 15563707
[TBL] [Abstract][Full Text] [Related]
5. No paradoxical bronchodilator response with forced oscillation technique in children with cystic fibrosis.
Hellinckx J; De Boeck K; Demedts M
Chest; 1998 Jan; 113(1):55-9. PubMed ID: 9440568
[TBL] [Abstract][Full Text] [Related]
6. Progression of pulmonary hyperinflation and trapped gas associated with genetic and environmental factors in children with cystic fibrosis.
Kraemer R; Baldwin DN; Ammann RA; Frey U; Gallati S
Respir Res; 2006 Nov; 7(1):138. PubMed ID: 17137500
[TBL] [Abstract][Full Text] [Related]
7. Improved air trapping evaluation in chest computed tomography in children with cystic fibrosis using real-time spirometric monitoring and biofeedback.
Kongstad T; Buchvald FF; Green K; Lindblad A; Robinson TE; Nielsen KG
J Cyst Fibros; 2013 Dec; 12(6):559-66. PubMed ID: 23810566
[TBL] [Abstract][Full Text] [Related]
8. Peripheral airway involvement in CF and asthma compared by inert gas washout.
Gustafsson PM
Pediatr Pulmonol; 2007 Feb; 42(2):168-76. PubMed ID: 17186546
[TBL] [Abstract][Full Text] [Related]
9. Treatment response of airway clearance assessed by single-breath washout in children with cystic fibrosis.
Abbas C; Singer F; Yammine S; Casaulta C; Latzin P
J Cyst Fibros; 2013 Dec; 12(6):567-74. PubMed ID: 23790270
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of ventilation maldistribution as an early indicator of lung disease in children with cystic fibrosis.
Gustafsson PM; Aurora P; Lindblad A
Eur Respir J; 2003 Dec; 22(6):972-9. PubMed ID: 14680088
[TBL] [Abstract][Full Text] [Related]
11. Lung Clearance Index (LCI) in Patients with Bronchiolitis Obliterans: A Preliminary Report and Comparison to Cystic Fibrosis Patients.
Gur M; Yaacoby-Bianu K; Ilivitzki A; Bar-Yoseph R; Nir V; Hakim F; Toukan Y; Bentur L
Lung; 2016 Dec; 194(6):1007-1013. PubMed ID: 27645685
[TBL] [Abstract][Full Text] [Related]
12. Variability of lung clearance index in clinically stable cystic fibrosis lung disease in school age children.
Svedberg M; Gustafsson PM; Robinson PD; Rosberg M; Lindblad A
J Cyst Fibros; 2018 Mar; 17(2):236-241. PubMed ID: 28822728
[TBL] [Abstract][Full Text] [Related]
13. Volume of trapped gas (VTG) during provoked asthma and after inhalation of salbutamol.
Bülow K; Arborelius M; Cristensson P; Lilja B
Scand J Respir Dis Suppl; 1977; 101():29-34. PubMed ID: 272737
[No Abstract] [Full Text] [Related]
14. Effect of Salbutamol on Lung Ventilation in Children with Cystic Fibrosis: Comprehensive Assessment Using Spirometry, Multiple-Breath Washout, and Functional Lung Magnetic Resonance Imaging.
Kieninger E; Willers C; Röthlisberger K; Yammine S; Pusterla O; Bauman G; Stranzinger E; Bieri O; Latzin P; Casaulta C
Respiration; 2022; 101(3):281-290. PubMed ID: 34808631
[TBL] [Abstract][Full Text] [Related]
15. Lung Clearance Index in Adults and Children With Cystic Fibrosis.
O'Neill K; Tunney MM; Johnston E; Rowan S; Downey DG; Rendall J; Reid A; Bradbury I; Elborn JS; Bradley JM
Chest; 2016 Dec; 150(6):1323-1332. PubMed ID: 27395423
[TBL] [Abstract][Full Text] [Related]
16. A randomized controlled trial to evaluate the lung clearance index as an outcome measure for early phase studies in patients with cystic fibrosis.
Amin R; Stanojevic S; Kane M; Webster H; Ratjen F
Respir Med; 2016 Mar; 112():59-64. PubMed ID: 26856191
[TBL] [Abstract][Full Text] [Related]
17. The Value of Measuring Inspiratory Capacity in Subjects With Cystic Fibrosis.
Vilozni D; Dagan A; Lavie M; Sarouk I; Bar-Aluma BE; Ashkenazi M; Mendelovich SL; Betzalel Y; Efrati O
Respir Care; 2018 Aug; 63(8):981-987. PubMed ID: 30018173
[TBL] [Abstract][Full Text] [Related]
18. Second-order Texture Measurements of (3)He Ventilation MRI: Proof-of-concept Evaluation of Asthma Bronchodilator Response.
Zha N; Pike D; Svenningsen S; Capaldi DP; McCormack DG; Parraga G
Acad Radiol; 2016 Feb; 23(2):176-85. PubMed ID: 26601971
[TBL] [Abstract][Full Text] [Related]
19. Obstruction of the respiratory pathways, its evaluation by methods of functional examination of the lungs and development in patients with cystic fibrosis.
Houstĕk J; Zapletal A; Samánek M; Vávrová V
Czech Med; 1979; 2(1-2):1-10. PubMed ID: 527420
[TBL] [Abstract][Full Text] [Related]
20. Lung Clearance Index to Track Acute Respiratory Events in School-Age Children with Cystic Fibrosis.
Perrem L; Stanojevic S; Shaw M; Jensen R; McDonald N; Isaac SM; Davis M; Clem C; Guido J; Jara S; France L; Solomon M; Grasemann H; Waters V; Sweezey N; Sanders DB; Davis SD; Ratjen F
Am J Respir Crit Care Med; 2021 Apr; 203(8):977-986. PubMed ID: 33030967
[No Abstract] [Full Text] [Related]
[Next] [New Search]
